The Scientific World Journal / 2012 / Article / Tab 2

Clinical Study

Whey Protein Lycosome Formulation Improves Vascular Functions and Plasma Lipids with Reduction of Markers of Inflammation and Oxidative Stress in Prehypertension

Table 2

Changes in lipid profile in prehypertensive patients treated with whey protein and lycopene formulations.

ProductTCTGLDLHDL
in mg/dLin mg/dLin mg/dLin mg/dL

WP baseline after 1 month (n = 10)215 ± 9.9147 ± 10.1133 ± 13.240.7 ± 0.6
222 ± 11.3151 ± 12.3132 ± 11.540.9 ± 0.7
P > 0.05P > 0.05P > 0.05P > 0.05

Lycopene baseline after 1 month (n = 10)199 ± 10.2145 ± 9.4142 ± 9.938.5 ± 0.7
191 ± 9.8139 ± 10.1141 ± 8.739.1 ± 0.6
P > 0.05P > 0.05P > 0.05P > 0.05

WPL baseline after 1 month (n = 10)209 ± 9.1148 ± 14.5159 ± 11.039.6 ± 1.2
180 ± 8.097.5 ± 7.5132 ± 7.844.5 ± 1.1
P < 0.05*P < 0.01*P < 0.05*P < 0.05*

Placebo baseline after 1 month (n = 10)185 ± 10.3135 ± 11.2146 ± 12.440.1 ± 1.0
182 ± 9.6141 ± 10.5144 ± 11.740.6 ± 0.9
P > 0.05P > 0.05P > 0.05P > 0.05

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.